Department of Cardiology, West China Hospital, Sichuan University, Chengdu, PR China.
Circ Cardiovasc Interv. 2013 Oct 1;6(5):543-51. doi: 10.1161/CIRCINTERVENTIONS.113.000529. Epub 2013 Sep 24.
There were considerable discrepancies with regard to sex-related differences in complications and prognosis after transcatheter aortic valve implantation.
The Cochrane library and PubMed online databases were searched. Articles reporting sex-specific post-transcatheter aortic valve implantation complications and mortality were identified. Two authors selected studies and extracted data independently. Random- and fixed-effects models were used depending on between-study heterogeneity. There were 27 articles, a total of 9118 patients, enrolled in our systematic review and meta-analysis, including 4176 men and 4942 women. Pooled analyses suggested considerable sex-related differences in complications and early as well as midterm outcomes after transcatheter aortic valve implantation. The difference in the risk for heart block requiring permanent pacemaker implantation was noted to be significant only in the subgroup of the CoreValve-dominating studies (pooled risk ratio [RR, men versus women], 1.29; 95% confidence interval [CI], 1.13-1.47). Although men had significantly lower risks for major/life-threatening bleeding (pooled RR, 0.81; 95% CI, 0.68-0.96) and major vascular complications (pooled RR, 0.49; 95% CI, 0.37-0.66), they had poorer prognosis. In fact, male sex was associated with significantly higher risks for deaths at both 30 days (RR, 1.37; 95% CI, 1.07-1.76) and 1 year (RR, 1.30; 95% CI, 1.14-1.49).
Although men had lower risks for major/life-threatening bleeding and major vascular complications after transcatheter aortic valve implantation, they had less favorable short-term and midterm survival.
经导管主动脉瓣置换术后,并发症和预后方面存在明显的性别差异。
检索 Cochrane 图书馆和 PubMed 在线数据库。确定了报告经导管主动脉瓣置换术后特定性别并发症和死亡率的文章。两位作者独立选择研究并提取数据。根据研究间异质性,使用随机效应和固定效应模型。我们的系统评价和荟萃分析共纳入 27 篇文章,共 9118 例患者,其中包括 4176 名男性和 4942 名女性。汇总分析表明,经导管主动脉瓣置换术后并发症以及早期和中期结果存在明显的性别差异。需要永久性起搏器植入的心脏传导阻滞风险的差异仅在 CoreValve 主导研究的亚组中具有统计学意义(汇总风险比[RR],男性与女性,1.29;95%置信区间[CI],1.13-1.47)。尽管男性发生主要/危及生命的出血(汇总 RR,0.81;95%CI,0.68-0.96)和主要血管并发症(汇总 RR,0.49;95%CI,0.37-0.66)的风险显著降低,但他们的预后较差。事实上,男性性别与 30 天(RR,1.37;95%CI,1.07-1.76)和 1 年(RR,1.30;95%CI,1.14-1.49)时的死亡风险显著增加相关。
尽管男性经导管主动脉瓣置换术后发生主要/危及生命的出血和主要血管并发症的风险较低,但他们的短期和中期生存率较差。